22
Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Embed Size (px)

Citation preview

Page 1: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Hepatic Pathology and Respiratory SystemTopics in Human Pathophysiology Fall 2011Gilead Drug Safety and Public Health

Page 2: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Outline

Hepatic Pathophysiology Digestive System Overview Placement and role of liver Liver microstructure Pathologies of liver

Respiratory Structure and Function

Page 3: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Digestive system

Page 4: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

The Liver

Part of digestive system

Located in upper right abdominal quadrant

Is served by two blood vessels: the hepatic portal vein, the hepatic artery

Has one duct that carries bile away from it to the gall bladder for storage

Composed of lobules that contain hepatocytes

Blood moves easily from the external vessels, in porous capillaries past the hepatocytes to a central vein

Hepatocytes do the work of the liver

Page 5: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Figure 14.11

Page 6: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Hepatic Portal System

Page 7: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Liver Functions

Secretes bile – which emulsifies fats within small intestine

Metabolizes bilirubin - a breakdown product of hemoglobin

Produces albumin, and clotting factors

Metabolizes fats, proteins, carbohydrates, stores glycogen, makes HDLs and LDLs

Inactivates many biologically active chemicals including alcohol, medicinal and recreational drugs, hormones, poisons

Stores fat soluble vitamins and iron

Converts ammonia (NH3) into soluble urea to be excreted by kidneys

Page 8: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health
Page 9: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health
Page 10: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Hepatitis

• Inflammation of the liver• Causes include:

• Viruses and other pathogens

• Drug and alcohol toxicity

• Environmental toxins• Obesity, autoimmune

disorders

Page 11: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Viral Hepatitis

Hepatitis A (HAV)

Hepatitis B (HBV) Hepatitis C (HCV)

Etiology Causes mild acute illness- hepatocyte injury

Causes acute illness and chronic liver disease, can lead to liver cancer

May cause acute illness, acts long term leading to chronic liver disease and risk of liver cancer

Mode of transmission

Fecal-oralprimarily in children, young adults

Contact with infected body fluids – blood, semen; contaminated needles, mother to newborn

Contact with infected blood, mostly through contaminated needles

Vaccination Hep A vaccine Hep B vaccine No vaccineFrom http://www.cdc.gov/hepatitis/index.htm

Page 12: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Figure 9.20

Reverse transcriptase required

Page 13: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Pathophysiology of Hepatitis

Destruction of hepatocytes (necrosis) by inflammation

Altered blood flow through and to liver

Edema – both peripherally and in portal vessel area

Blockage of bile ducts leading to reduced bile in small intestine and problems with fat absorption

Reduction of ability to make blood proteins including albumin, clotting factors, complement

Buildup of blood toxins including urea and ammonia

Page 14: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Symptoms of Hepatic Damage Jaundice

Dark amber colored urine

Nausea/vomiting

Abdominal pain - R upper quad

Fatigue

Also- ascites, hepatic encephalopathy, coma, death

Page 15: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Cirrhosis Long term

result of liver damage

Page 16: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Liver Tests – Liver Panel

AST– liver enzyme, elevated with damage to cells

ALT - liver enzyme, elevated with damage to cells

ALP – enzyme related to bile ducts, levels elevate if there is a blockage

total bilirubin (blood)– may be elevated with liver damage or excessive RBC destruction

Albumin (blood) – checks on synthetic ability of liver cells

prothrombin time - decreased synthesis of clotting factors by liver

See labtestsonline for more information

Page 17: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

CT Scan of the Liver

17

Nodular cirrhotic liver with ascitesNormal liver

www.integris-health.com

Page 18: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Drug Induced Hepatotoxicity More than 900 drugs, toxins

and herbs cause drug induced hepatotoxicity,

20-40% of all fulminant liver failure cases are caused by drug induced hepatotoxicity

It is the most common reason a drug is withdrawn from approval

Damage to liver can be hepatocellular or cholestatic

Drug-Induced Hepatotoxicity from http://www.emedicine.com/Med/topic3718.htm

Page 19: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Figure 10.1

Respiratory System

Page 20: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Gas exchange

Protection

Speech

Compression of abdomen and spine stiffening

Acid-Base balance

Respiratory Functions

Page 21: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Figure 10.8

Page 22: Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health

Respiratory Interface

Alveolar wall

Capillary wall

Surfactant

Gas Exchange occurs by diffusion